Drug details

Baqsimi (glucagon nasal powder)

type of Hypoglycemia Antidotes, Glucose-Elevating Agents

Baqsimi (glucagon) Nasal Powder is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above.

The drug is often used to treat Diabetes .

This drug may have the following side effects:

• nausea,
• vomiting,
• headache,
• eye redness,
• watery eyes,
• sneezing, and
• itchy nose, throat, and eyes

The following drugs are related to Baqsimi, either as a replacement or used together:

• Precose (acarbose)
• Actos (pioglitazone hydrochloride)
• Amaryl Tablets (glimepiride)
• Avandia (rosiglitazone maleate)
• Diabinese (chlorpropamide)
• Glucotrol (glipizide)
• Glucotrol XL (glipizide extended release)
• Gvoke (glucagon injection)
• Glucophage, Glucophage XR (metformin hcl)
• Glyset (miglitol)
• Toujeo U 300 (insulin glargine injection for subcutaneous use)
• Novolin N (insulin isophane)
• Rybelsus (semaglutide tablets)
• Tolinase (tolbutamide tablets)